MYC and B-cell chronic lymphocytic leukemia: Given the multifaceted role of MYC activation, we analyzed its correlation with other pathways to deepen our understanding of its impact in CLL and RT phase (FDR < 0.01 and |r| = 0.3) (Figure 1d).